Stimulant Medication Use in College Students: Comparison of Appropriate Users, Misusers, and Nonusers by Canu, Will & NC DOCKS at Appalachian State University
Archived version from NCDOCKS Institutional Repository http://libres.uncg.edu/ir/asu/ 
Stimulant Medication Use in College Students: 
Comparison of Appropriate Users, Misusers, and Nonusers
Authors
Cynthia M. Hartung, Carolyn S. Cleveland, Melissa J. Mignogna, Christopher J. Correia, 
Will H. Canu, Elizabeth K. Lefler, David A. Fedele, Thad R. Leffingwell
Abstract
While stimulant medication is commonly prescribed to treat Attention-Deficit/Hyperactivity 
Disor-der in children and adolescents (Merikangas, He, Rapoport, Vitiello, & Olfson, 2013; Zuvekas 
& Vitiello, 2012) and is considered an empirically supported intervention for those groups (Barkley, 
Murphy, & Fischer, 2008; Pelham & Fabiano, 2008; Safren et al., 2005) surprisingly little is known 
about the efficacy of stimulants in the slightly older emerging adult population. A focus has 
emerged, however, on illicit stimulant use among undergraduates, with studies suggesting such 
behavior is not uncommon (e.g., Arria et al., 2013). Unfortunately, details are lacking regarding 
outcomes and personal characteristics associated with different patterns of stimulant misuse. The 
current study compares the characteristics of four groups of college students, including those with 
stimulant prescriptions who use them appropriately (i.e., appropriate users), those who misuse their 
prescription stimulants (i.e., medical misusers), those who obtain and use stimulants without a 
prescription (i.e., nonmedical misusers), and those who do not use stimulant medications at all (i.e., 
nonusers). Undergraduates (N � 1,153) from the Southeastern, Midwest, and Rocky Mountain 
regions completed online measures evaluating patterns of use, associated motives, side effects, 
ADHD symptomatology, and other substance use. Both types of misusers (i.e., students who abused 
their prescriptions and those who obtained stimulants illegally) reported concerning patterns of 
other and combined substance use, as well as higher prevalence of debilitating side effects such as 
insomnia and restlessness. Research and practical implications are discussed.
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Studies estimate a 4 –14% yearly incidence of nonprescribed 
stimulant medication use in college students (American College 
Health Association [ACHA], 2010; Hall, Irwin, Bowman, Fran- 
kenberger, & Jewett, 2005; McCabe, Teter & Boyd, 2006; Wey- 
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andt et al., 2009; White, Becker-Blease, & Grace-Bishop, 2006), 
which is higher than the national prevalence of cocaine, halluci- 
nogen, or inhalant use (SAMHSA, 2011), and approximately dou- 
ble the prevalence of prescribed stimulant use (2–3%; Babcock & 
Byrne, 2000; Stone & Merlo, 2011) in this age group. In consid- 
ering stimulant abuse, however, it is important to note that not all 
who use illicitly are qualitatively similar. While motive (e.g., 
getting high vs. increasing concentration) is one way to categorize 
stimulant users (Teter, McCabe, Cranford, Boyd & Guthrie, 2005), 
means and degree of use differentiate among (a) medical misusers 
(i.e., those with a prescription who periodically use excessive 
doses), (b) nonmedical misusers (i.e., those who obtain and use 
stimulants illegally), and (c) appropriate users (i.e., those who use 
prescription according to instructions). The need for closer exam- 
ination of these groups is underscored by the somewhat ambiguous 
stimulant-related maladjustment (Bogle & Smith, 2009), and in- 
frequent and incomplete differentiation among misuser groups in 
the literature. 
Although prevalence estimates vary widely (e.g., 4%, McCabe, 
Knight, Teter, & Wechsler, 2005; 38%, Arria et al., 2013; 43%, 
Advokat, Guidry, & Martino, 2008), it seems likely that a sub- 
stantial number of college students misuse stimulants (DeSantis, 
Webb, & Noar, 2008). In contrast to prescribed use of stimulants 
in college students with Attention-Deficit/Hyperactivity Disorder 
(ADHD; DuPaul, Weyandt, O’Dell, & Varejao, 2009), which 
some have suggested ameliorates maladjustment (Staufer & Grey- 
danus, 2005), nonmedical misuse is correlated with lower grades 
(McCabe et al., 2005), academic concerns (Rabiner et al., 2009), 
risk for polysubstance abuse (Rozenbroek & Rothstein, 2011), and 
a desire to improve studying (Stone & Merlo, 2011). However, 
unaddressed symptoms of ADHD may be linked to nonmedical 
misuse of stimulants too, with one study finding that 12% of 
nonmedical misusers believed they had the disorder (Advokat et 
al., 2008). It is also possible that students without ADHD use 
stimulants to enhance academic performance (Smith & Farah, 
2011), as staying awake and increasing studying efficiency are 
frequent rationales for misuse (Advokat et al., 2008). 
While addressing undiagnosed or undertreated ADHD and re- 
lated academic problems is a motive for misuse that parallels the 
intended purpose of prescription stimulants, recreation (i.e., eu- 
phoric effects; Teter et al., 2005) and socialization (White et al., 
2006) are not uncommonly endorsed as reasons for use. This may 
be particularly prevalent in nonmedical misusers, as approximately 
one fifth of this group reports using stimulants while drinking 
(Low & Gendaszek, 2002), and to prolong intoxication (Rabiner et 
al., 2009). Some have suggested that stimulant use may be even 
more reinforcing in social situations, as the resulting alertness may 
facilitate prolonged social engagement (Hall et al., 2005). How- 
ever, recreational motives for stimulant abuse do not outrank 
academic motives among nonmedical misusers, and are uncom- 
monly the sole motive reported (Rabiner et al., 2009). 
Specific personality characteristics have also been related to 
stimulant misuse, with both sensation seeking (Arria, Caldeira, 
Vincent, O’Grady & Wish, 2008) and perfectionism (Low & 
Gendaszek, 2002) positively predicting this behavior in college 
populations. Further, men appear more likely than women to 
misuse stimulants (Bogle & Smith, 2009; Hall et al., 2005; see 
exception in McCabe et al., 2005), which may be due to sex 
differences in risk-taking (Byrnes, Miller & Schafer, 1999) or 
knowledge about from whom one can illicitly obtain stimulants 
(Hall et al., 2005). 
Immediate adverse consequences of stimulant use have been 
reported in college student nonmedical misuser samples, in- 
cluding appetite reduction (63%), sleep problems (60%), irri- 
tability (45%), and reduced academic self-efficacy (41%; Ra- 
biner et al., 2009). Taken with the potential legal consequences 
of illicit use of a Schedule II substance (e.g., methylphenidate) 
and increased risk of polysubstance abuse, this suggests illicit 
stimulant use is associated with risk across several domains. 
However, particularly given some studies suggesting relatively 
mild and circumscribed maladjustment in misusing college 
students (e.g., Bogle & Smith, 2009), replication and further 
detailing of the putative adverse consequences associated with 
illicit stimulant use is a valid aim, especially given the potential 
downside of overly negative portrayals (e.g., Food and Drug 
Administration caps on production). 
This study examined four college student groups differentiated 
by type of stimulant use (i.e., nonusers, nonmedical and medical 
misusers, appropriate users). Given the extant literature, hypothe- 
ses were as follows: (a) both misuser groups were expected to 
more frequently nominate recreational motives for stimulant use; 
(b) misusers, given their nonprescribed drug use, were expected to 
endorse high rates of other illicit substance use (i.e., concurrent to 
stimulant use or at other times in the past year); (c) nonmedical 
misusers would report more ADHD-related symptomatology (i.e., 
inattention, hyperactivity) than nonusers, but less than either ap- 
propriate users or medical misusers; (d) nonmedical misusers 
would be distinguished by high sensation seeking and perfection- 
ism. Finally, other planned analyses examined whether groups 
differed on other motives for use, side effects, and methods of 
ingestion; however, given a relative dearth of direction from prior 
research for these variables, specific hypotheses were not made. 
Method 
Participants 
Participants were 1,153 undergraduates (65.2% female; 88.4% 
European American) from four public universities located in the 
Southeast (n 2), Rocky Mountain (n 1), and Midwest (n  1) 
regions of the United States who were compensated with class 
credit. The mean age of these participants was 19.72 years (SD  
1.45; range: 18 –25). Distribution by class standing was 46.2% 
freshmen, 24.0% sophomores, 16.8% juniors, and 13.0% seniors. 
Based on self-reported stimulant use, groups included (a) nonusers 
(n 708), (b) nonmedical misusers (i.e., illicitly obtaining and 
using stimulant medication without a prescription; n 274), (c) 
appropriate users (i.e., taking stimulants according to prescription; 
n 146), and (d) medical misusers (i.e., using higher doses or 
more frequently than prescribed; n 25). Agreement regarding 
group assignment was 100% (consensus of first, second, and 
fourth authors). At two of four universities, stimulant users were 
overselected via a prescreening questionnaire. Thus, the distribu- 
tions across user status do not reflect the true prevalence of use and 
misuse on these college campuses. 
Measures and Procedure 
Participants completed all rating scales online in a fixed order 
after providing informed consent. Study procedures were approved 
by each university’s Institutional Review Board. 
Substance use. Participants reported whether they used a va- 
riety of legal and illegal substances in the past year (e.g., alcohol, 
cigarettes, marijuana). They also reported whether they used sub- 
stances concurrently with prescription stimulants. Previous studies 
support the reliability and validity of self-reported substance use 
(Tucker, Murphy, & Kertesz, 2010), and endorsement of 12-month 
substance use or nonuse is also consistent with prior research in 
this area (e.g., Johnston, O’Malley, Bachman, & Schulenberg, 
2013; Mohler-Kuo, Lee, & Wechsler, 2003; SAMHSA, 2011). 
Stimulant use. Students were asked about: (a) use (e.g., “I 
have a prescription and take accordingly”; “I do not have a 
prescription but obtain stimulants and use them”; see White et al., 
2006), (b) source for obtaining (e.g., received from my doctor/ 
pharmacy, given by a friend/family member, or bought or stolen 
from someone; based on McCabe, Teter, & Boyd, 2006), (c) 
method of ingestion (e.g., oral, intranasal, or intravenous; as per 
Teter et al., 2005), (d) reasons for use (e.g., control ADHD 
symptoms, suppress appetite, or stay awake; adapted from Low & 
Gendaszek, 2002), and (e) side effects experienced while taking 
stimulants (e.g., insomnia, loss of appetite, or weight loss). 
ADHD symptoms. ADHD symptoms were measured with an 
18-item self-report measure of DSM–IV inattention and hyperac- 
tivity (Barkley & Murphy, 2006). Participants indicated whether 
they never/rarely (0), sometimes (1), often (2), or very often (3) 
experienced each symptom. Summary scores were created for 
inattention and hyperactivity. Internal consistency has been good 
for inattention (a= .80) and adequate for hyperactivity (a=.73) 
based on college student self-reports (e.g., Fedele, Hartung, Canu, 
& Wilkowski, 2010). In addition, interrater reliability has been 
found to be moderately high in adults (e.g., r= .67; Barkley, 
Knouse, & Murphy, 2011). Convergent and discriminant validity 
have also been demonstrated for adult self-reports (e.g., Magnus- 
son et al., 2006). Internal consistency in the current sample was 
good for inattention (a=.87) and adequate for hyperactivity (a 
=.76). 
Personality characteristics. Sensation seeking was measured 
using a 16-item version (Donohew et al., 2000) of the Sensation 
Seeking Scale (Zuckerman, 1994). Responses were disagree a lot 
(0), disagree a little (1), don’t agree or disagree (2), agree a little 
(3), or agree a lot (4) and were aggregated into a summary score 
(range 0 to 64). Previous reports of internal consistency were 
adequate (a = .79; Donohew et al., 2000) and internal consistency 
was good in the current sample (a= .82). Perfectionism was 
measured using a 24-item version (Khawaja & Armstrong, 2005) 
of the Frost Multi-Dimensional Perfectionism Scale (Frost, Mar-  
ten, Lahart, & Rosenblate, 1990). This version has been reported to 
have excellent internal consistency (a= .90) and strong concur- 
rent validity with other measures of perfectionism (Khawaja & 
Armstrong, 2005). Responses range from strongly disagree (0) to 
strongly agree (4). There are four subscales: concern over mistakes 
(10 items), organization (4 items), parental expectations (6 items), 
and high personal standards (4 items). Internal consistency was 
adequate for parental expectations (a= .79), good for organiza- 
tion (a = .88) and concern over mistakes (a=.87), but 
inadequate 
for high personal standards (a .64). Accordingly, the latter was 
omitted from analyses. 
Results 
Multinomial logistic regression analyses were conducted to ex- 
amine relations between predictors and user status. For some 
analyses, all four user status groups were included. For other 
analyses, nonusers were not included because the items were not 
relevant (e.g., reasons for use, side effects). For all analyses, sex 
and university were entered as covariates due to significant differ- 
ences across user status. In keeping with prior findings (e.g., Bogle 
& Smith, 2009), men were more likely to engage in nonmedical 
misuse than women (p .009). Alpha corrections were conducted 
for all analyses and resulting p values are noted in each of the 
tables. For each regression, likelihood (i.e., x2) and pairwise odds 
ratios representing the unique relation between predictor and out- 
come variable (i.e., user status) are reported. 
First, a logistic regression analysis was conducted to examine 
the relation between reasons for stimulant use and user status (see 
Table 1). We were particularly interested in using “to get high” as 
a measure of recreational use. However, we were not able to 
include this reason in the regression due to low levels of endorse- 
ment. Specifically, 13% of nonmedical misusers and 24% of 
medical misusers indicated using stimulants to get high (compared 
to none of appropriate users). With regard to other reasons for use, 
we conducted planned exploratory analyses. Results showed that 
both types of misusers endorsed some reasons significantly more 
often than appropriate users. Specifically, nonmedical and medical 
misusers were more likely to endorse using to stay awake than 
appropriate users. Also, nonmedical misusers were more likely to 
report using to study than appropriate users whereas medical 
misusers were more likely to endorse using to increase academic 
performance than appropriate users. Finally, both appropriate users 
and medical misusers were more likely to use “to control ADHD 
symptoms” than nonmedical misusers. 
Another logistic regression analysis was conducted to examine 
the relation between use of other substances and user status (see 
Table 2). Across eight substances, nonusers of stimulants were the 
least likely to endorse use of other substances, appropriate users 
were next in terms of likelihood to endorse, and misusers were the 
most likely to endorse. Although alcohol use was surveyed, it 
could not be entered in the regression because 100% of medical 
misusers endorsed it. 
Next, a logistic regression analysis was conducted to examine 
the relation between concurrent use of stimulants with other sub- 
stances and user status (see Table 3). Appropriate users were 
typically the least likely to endorse concurrent use of additional 
substances. Medical misusers were significantly more likely to 
endorse concurrent marijuana use than appropriate users. Nonmed- 
ical misusers were more likely to endorse concurrent marijuana 
and pain medication use than appropriate users. Interestingly, 
nonmedical misusers were significantly less likely to endorse 
concurrent alcohol use than appropriate users. 
Next, regressions were conducted to examine how user status 
related to ADHD and personality variables (see Table 4). Nonusers 
reported significantly lower levels of inattention and hyperactivity 
than any other group. In addition, nonmedical misusers reported 
lower levels of inattention than appropriate users and lower levels 
Table 1 
Multinomial Logistic Regression Analysis for Reasons for Stimulant Use by User Status 
Comparisons 
Nonmedical misusers vs. 
appropriate users 
Medical misusers vs. appropriate 
users 
Nonmedical misusers vs. medical 
misusers Omnibus 
NMM% AU% OR SE MM% AU% OR SE NMM% MM% OR SE x2(2, 443) 
Stay awake 49.6 18.5 3.77*** 0.33 60.0 18.5 5.01** 0.53 49.6 60.0 0.75 0.53 21.51 
Study 81.0 63.7 3.24** 0.36 84.0 63.7 0.93 0.71 81.0 84.0 3.48 0.73 11.94 
Academics 54.0 61.0 0.73 0.35 96.0 61.0 13.93* 1.11 54.0 96.0 0.05** 1.10 12.26 
Alertness 39.8 44.5 0.70 0.34 64.0 44.5 0.56 0.55 39.8 64.0 1.26 0.55 1.64 
Control ADHD 11.3 69.2 0.06*** 0.30 68.0 69.2 0.71 0.52 11.3 68.0 0.08*** 0.50 129.78 
Weight control 13.5 6.8 1.69 0.51 28.0 6.8 2.54 0.64 13.5 28.0 0.67 0.60 2.30 
(Get “high”) 13.1 0.0 — — 24.0 0.0 — — 13.1 24.0 — — — 
Note.    NMM    Nonmedical misusers (n    274); MM    Medical misusers (n    25); AU    Appropriate users (n    146). OR     Odds ratio, calculated 
with the group in BOLD in the subheader (e.g., for NMM vs. AU, NMM) as the criterion and the other as the reference. SE Standard error of the effect. 
Sex and university/site were entered as covariates at the first step of this logistic regression analysis. Get “high” was not included in logistic regression 
analyses due to nil endorsement by appropriate users, a violation of logistic regression assumptions. Alpha for each omnibus x2 test was set at .008 to 
compensate for family-wise error (6 predictors used in regressions; .05/6      .008; x2  values in italics are p < .008). 
* p < .05. ** p < .01.  *** p < .001 (for pairwise OR). 
of hyperactivity than medical misusers. With regard to personality, 
nonmedical misusers reported higher parental expectations than 
nonusers and appropriate users. Moreover, nonmedical misusers 
reported higher levels of sensation seeking than appropriate users 
and nonusers. 
Exploratory analyses were conducted to examine differences 
across user groups for side effects, stimulant source, and ingestion. 
An analysis was conducted to examine the relation between side 
effects and user status (see Table 5). Overall, misusers appeared to 
experience more side effects; both misuser groups were signifi- 
cantly more likely to endorse exaggerated well-being and restless- 
ness than appropriate users. In addition, nonmedical misusers were 
more likely to report insomnia and exaggerated well-being—and 
less likely to report weight loss, anxiety, or gastrointestinal prob- 
lems—than appropriate users. Finally, medical misusers were 
more likely to endorse changes in sex drive than nonmedical 
misusers. 
Finally, sources for obtaining stimulants and ingestion methods 
were examined. No regression analysis could be conducted for 
these variables because appropriate users obtained their stimulants 
exclusively from prescriptions and participants reported oral in- 
gestion as their primary method. Notably, among nonmedical 
misusers, 81% got stimulants from a friend, 45% bought them, and 
4% stole them. Additionally, nasal ingestion among nonmedical 
(17.9%) and medical misusers (20.0%) was much higher than for 
appropriate users (0.0%) although the difference between the two 
misuser groups was not significant. 
Discussion 
The purpose of this study was to compare characteristics of 
undergraduates who use, misuse, and do not use prescription 
stimulants. Overall, those classified as misusers (i.e., medical and 
nonmedical) presented relatively more concerning correlates than 
those who used stimulants according to prescription. First, al- 
though not statistically analyzed due to nonendorsement by all 
appropriate users, both medical and nonmedical misusers more 
frequently equate stimulant ingestion with recreation (i.e., getting 
high). Further, misusers appeared to experience different side 
effects. Notably, both misuser groups were more likely to endorse 
exaggerated well-being and restlessness than appropriate users. 
Nonmedical misusers were more likely to endorse insomnia than 
appropriate users, but less likely to have experienced anxiety, 
weight loss, or digestive problems. Unfortunately, “desirable” side 
effects (e.g., exaggerated well-being) may encourage misuse by 
off-setting negative consequences and reinforcing the expectation 
of euphoria. 
Perhaps not surprisingly, misusers reported the highest rates 
of other substance use. Nonmedical misusers were more likely 
to report use of marijuana and hallucinogens than nonusers and 
appropriate users. Medical misusers were the most likely en- 
dorsers for all substances but these differences only reached 
statistical significance when compared to nonusers for ciga- 
rettes, amphetamines, and anxiety medication. When examining 
substances frequently used by college students (e.g., alcohol 
and marijuana; ACHA, 2010), appropriate users were more 
likely than nonusers to endorse use of these substances. This 
finding is consistent with prior research suggesting that ADHD 
is associated with increased risk for substance use (Wilens,  
2004), but seems to contradict a documented protective effect 
of stimulant treatment (Biederman, 2003; Faraone & Wilens, 
2003; Wilens, Faraone, Biederman, & Bunawardene, 2003). 
However, the current data cannot inform the prospective influ- 
ence of stimulant intervention in childhood. Overall, it seems 
reasonable to conclude that stimulant misuse is associated with 
risk for broader substance use. 
With regard to concurrent substance use, misusers were more 
likely than appropriate users to report marijuana use in combina- 
tion with stimulants. In addition, nonmedical misusers were sig- 
nificantly more likely to endorse concurrent pain medication use 
than appropriate users. Such recreational use suggests that the 
motives of misusers may not be benign (e.g., extra dose for finals). 
This is consistent with other studies in which students frequently 
endorsed using stimulants while “partying” (e.g., Teter et al., 2005;  
White et al., 2006), and those in which short-term positive gain is 
Table 2 
Multinomial Logistic Regression Analyses for Use of Other Substances 
Comparisons 
Nonmedical misusers vs. medical 
misusers 
Nonmedical misusers vs. 
appropriate users Nonmedical misusers vs. nonusers Omnibus 
NMM% MM% OR SE NMM% AU% OR SE NMM% NU% OR SE x2(3, 1050) 
Cigarettes 62.1 76.0 0.32 0.62 62.1 44.8 0.91 0.27 62.1 24.7 1.30 0.21 7.32 
Cigars/chew 40.4 37.5 1.20 0.57 40.4 27.1 1.74 0.30 40.4 18.2 1.84* 0.25 6.68 
Marijuana 72.2 70.8 1.69 0.57 72.2 45.5 2.90** 0.26 72.2 24.3 4.40*** 0.21 54.26 
Amphetamines 18.6 20.0 0.72 0.71 18.6 4.2 2.30 0.54 18.6 0.6 4.77* 0.60 10.26 
Hallucinogens 26.3 12.0 3.11 0.78 26.3 6.9 2.84* 0.45 26.3 1.9 4.36*** 0.40 17.69 
Ecstasy 17.8 16.0 0.96 0.68 17.8 4.9 1.63 0.48 17.8 1.0 2.53 0.49 4.30 
Anxiety meds 34.5 44.0 0.71 0.53 34.5 24.7 0.78 0.29 34.5 6.1 2.70*** 0.27 23.36 
Pain meds 34.3 40.0 0.90 0.52 34.3 20.8 1.33 0.30 34.3 12.8 1.25 0.25 1.39 
(Alcohol) 97.8 100.0 — — 97.8 90.4 — — 97.8 77.4 — — — 
Medical misusers vs. appropriate 
Comparisons 
users Medical misusers vs. nonusers Appropriate users vs. Nonusers 
MM% AU% OR SE MM% NU% OR SE AU% NU% OR SE 
Cigarettes 76.0 44.8 2.84 0.63 76.0 24.7 4.02* 0.61 44.8 24.7 1.42 0.24 
Cigars/chew 37.5 27.1 1.45 0.60  37.5 18.2 1.53 0.58 27.1 18.2 1.06 0.28 
Marijuana 70.8 45.5 1.24 0.58  70.8 24.3 2.61 0.56 45.5 24.3 2.10
** 0.23 
Amphetamines 20.0 4.2 3.20 0.83  20.0 0.6 6.64
* 0.88 4.2 0.6 2.08 0.74 
Hallucinogens 12.0 6.9 0.91 0.87  12.0 1.9 1.40 0.85 6.9 1.9 1.54 0.53 
Ecstasy 16.0 4.9 1.70 0.77  16.0 1.0 2.63 0.80 4.9 1.0 1.55 0.60 
Anxiety meds 44.0 24.7 1.10 0.56  44.0 6.1 3.83
* 0.55 24.7 6.1 3.48*** 0.29 
Pain meds 40.0 20.8 1.48 0.56  40.0 12.8 1.38 0.54 20.8 12.8 0.93 0.29 
(Alcohol) 100.0 90.4 — — 100.0 77.4 — — 90.4 77.4 — — 
Note.    NMM    Nonmedical misusers (n    274); MM    Medical misusers (n    25); AU    Appropriate users (n     146); NU     Nonusers (n  708). 
OR Odds ratio, calculated with group in BOLD in the subheader (e.g., for NMM vs. AU, NMM) as the criterion and the other as the reference. SE 
Standard error of the effect. Sex and university were entered as covariates at the first step. Alcohol was not included in regression because 100% of medical 
misusers endorsed using. Alpha was set at .006 to compensate for family-wise error (8 predictors; .05/8 .006; x2  values in italics are p < .006). Some 
substances were not included in the analyses because of lack of endorsement by any participant. 
* p < .05. ** p < .01.  *** p < .001 (for pairwise OR). 
reported with stimulant misuse (Rabiner et al., 2009) despite low 
endorsement of long-term academic gain (Hall et al., 2005). 
With regard to concurrent alcohol use, the three user groups 
reported relatively high rates, which is troubling due to potential 
interactions between alcohol and stimulants. Specifically, using 
stimulants in combination with alcohol may diminish the experi- 
ence of alcohol-related effects. This may in turn lead to underes- 
timation of inebriation (Flack et al., 2007; Hingson, Edwards, 
Heeren & Rosenbloom, 2009; Knight et al., 2002) and poor deci- 
sions (e.g., drunk driving, unsafe sexual activity) that could lead to 
Table 3 
Multinomial Logistic Regression Analyses for Concurrent Use of Other Substances and Stimulants 
Nonmedical misusers vs. appropriate 
users 
Comparisons 
Medical misusers vs. appropriate 
users 
Nonmedical misusers vs. medical 
misusers Omnibus 
NMM% AU% OR SE MM% AU% OR SE NMM% MM% OR SE x2(2, 443) 
Alcohol 43.1 52.1 0.41** 0.26 80.0 52.1 1.28 0.65 43.1 80.0 0.32 0.64 .001 
Tobacco 27.7 26.7 0.99 0.28  60.0 26.7 2.01 0.54  27.7 60.0 0.49 0.52  .348 
Marijuana 28.8 17.8 2.71** 0.31  56.0 17.8 3.40
* 0.55  28.8 56.0 0.80 0.52  .002 
Pain meds 12.0 4.8 3.81* 0.52  24.0 4.8 3.13 0.81  12.0 24.0 1.22 0.71  .023 
Anxiety meds 10.2 8.2 0.60 0.46 24.0 8.2 0.85 0.76 8.2 24.0 0.70 0.72 .512 
Note.    NMM    Nonmedical misusers (n    274); MM    Medical misusers (n    25); AU    Appropriate users (n    146). OR  Odds ratio, calculated 
with group in BOLD in the subheader (e.g., for NMM vs. AU, NMM) as the criterion and the other as the reference. SE Standard error of the effect. 
Sex and university/site were entered as covariates at the first step of this logistic regression analysis. Get “high” was not included in logistic regression 
analyses due to nil endorsement by appropriate users, a violation of logistic regression assumptions. Alpha for each omnibus x2 test was set at .01 to 
compensate for family-wise error (5 predictors used in regressions; .05/5   .01; x2  values in italics are p < .01). 
* p < .05. ** p < .01.  *** p < .001 (for pairwise OR). 
Table 4 
Multinomial Logistic Regression Analyses for (A) Inattention & Hyperactivity and (B) Perfectionism & Sensation Seeking by User Status 
Comparisons 
Nonmedical misusers vs. medical misusers Nonmedical misusers vs. appropriate users Nonmedical misusers vs. nonusers Omnibus 
NMM 
M(SD) MM M(SD) OR SE 
NMM 
M(SD) AU M(SD) OR SE 
NMM 
M(SD) NU M(SD) OR SE x2(3, 1050) 
Inattention 6.82 (4.87) 11.04 (5.94) 0.92 0.05 6.82 (4.87) 10.07 (5.90) 0.90*** 0.03 6.82 (4.87) 4.53 (3.74) 1.09*** 0.02 68.37 
Hyperactivity 7.05 (4.16) 10.70 (4.53) 0.89* 0.06 7.05 (4.16) 8.74 (4.63) 0.99 0.03 7.05 (4.16) 5.38 (3.53) 1.05* 0.02 12.04 
Perfectionism 
Parental expectations 12.06 (5.00) 12.56 (6.48) 1.03 0.05 12.06 (5.00) 10.87 (4.63) 1.10*** 0.02 12.06 (5.00) 10.78 (5.38) 1.04* 0.02 17.90 
Concern over mistakes 16.15 (7.72) 19.56 (9.55) 0.94* 0.03 16.15 (7.72) 18.54 (8.19) 0.94*** 0.02 16.15 (7.72) 15.39 (8.57) 0.99 0.01 27.23 
Organization 11.11 (3.82) 10.68 (5.02) 1.05 0.05 11.11 (3.82) 11.04 (3.87) 1.02 0.03 11.11 (3.82) 12.00 (3.53) 0.96* 0.02 11.01 
Sensation seeking 42.81 (9.69) 41.56 (9.01) 1.01 0.02 42.81 (9.69) 39.15 (10.91) 1.04** 0.01 42.81 (9.69) 36.44 (10.50) 1.07*** 0.01 66.19 
Comparisons 
Medical misusers vs. appropriate users Medical misusers vs. nonusers Appropriate users vs. nonusers 
MM M(SD) AU M(SD) OR SE MMM(SD) NU M(SD) OR SE AU M(SD) NU M(SD) OR SE 
Inattention 11.04 (5.94) 10.07 (5.90) 0.97 0.05 11.04 (5.94) 4.53 (3.74) 1.18*** 0.05 10.07 (5.90) 4.53 (3.74) 1.22*** 0.03 
Hyperactivity 10.70 (4.53) 8.74 (4.63) 1.11 0.06 10.70 (4.53) 5.38 (3.53) 1.18** 0.06 8.74 (4.63) 5.38 (3.53) 1.06* 0.03 
Perfectionism 
Parental expectations 12.56 (6.48) 10.87 (4.63) 1.07 0.05  12.56 (6.48) 10.78 (5.38) 1.01 0.05 10.87 (4.63) 10.78 (5.38) 0.95
* 0.02 
Concern over mistakes 19.56 (9.55) 18.54 (8.19) 0.99 0.03  19.56 (9.55) 15.39 (8.57) 1.05 0.03 18.54 (8.19) 15.39 (8.57) 1.06
*** 0.01 
Organization 10.68 (5.02) 11.04 (3.87) 0.98 0.06  10.68 (5.02) 12.00 (3.53) 0.91 0.05 11.04 (3.87) 12.00 (3.53) 0.93
** 0.03 
Sensation seeking 41.56 (9.01) 39.15 (10.91) 1.02 0.02 41.56 (9.01) 36.44 (10.50) 1.05* 0.02 39.15 (10.91) 36.44 (10.50) 1.03** 0.01 
Note.   NMM    Nonmedical misusers (n    274); MM    Medical misusers (n    25); AU    Appropriate users (n    146); NU    Nonusers (n    708). OR    Odds ratio, calculated with group in 
BOLD in the subheader (e.g., for NMM vs. AU, NMM) as the criterion and the other as the reference. SE Standard error of the effect. Sex and university/site were entered as covariates at the first 
step of these two logistic regression analyses. Values without a common superscript are statistically significantly different (p < .05). One logistic regression analysis was conducted for 
Inattention/Hyperactivity; a second logistic regression was conducted for Perfectionism/Sensation Seeking. Alpha was set at .025 to compensate for family-wise error (2 predictors; .05/2 .025; x2 
values in italics are p < .025) for the Inattention/Hyperactivity analysis. For the Perfectionism/Sensation Seeking analysis alpha was set at .013 (4 predictors; .05/4 x2 values in italics are p < .013). 
Range of scores for Inattention is 0 to 27, Hyperactivity is 0 to 27, Parental expectations is 0 to 24, Concern over mistakes is 0 to 40, Organization is 0 to 16, and Sensation Seeking range is 0 to 64. 
* p < .05. ** p < .01.  *** p < .001 (for pairwise OR). 
Table 5 
Logistic Regression Analysis for Various Side Effects of Stimulant Medication by User Status 
Nonmedical misusers vs. 
appropriate users 
Comparisons 
Medical misusers vs. appropriate 
users 
Nonmedical misusers vs. medical 
misusers Omnibus 
NMM% AU% OR SE MM% AU% OR SE NMM% MM% OR SE x2(2, 443) 
Change in sex drive 14.6 19.2 0.63 0.32 44.0 19.2 1.95 0.53 14.6 44.0 0.32* 0.50 5.81 
Gastrointestinal 6.2 12.3 0.40* 0.44 32.0 12.3 1.26 0.67 6.2 32.0 0.32 0.65 5.94 
Depressed mood 13.5 19.9 0.88 0.34 40.0 19.9 1.59 0.64 13.5 40.0 0.55 0.61 0.97 
Anxiety 25.5 33.6 0.52* 0.29 40.0 33.6 0.34 0.63 25.5 40.0 1.53 0.61 6.60 
Well-being 28.5 13.0 3.35*** 0.32 52.0 13.0 4.99** 0.55 28.5 52.0 0.67 0.50 18.67 
Dizziness 10.9 10.3 0.77 0.38 20.0 10.3 0.84 0.73 10.9 20.0 0.92 0.69 0.47 
Headache 20.1 21.2 0.85 0.31 32.0 21.2 0.83 0.62 20.1 32.0 1.03 0.60 0.30 
High blood pressure 8.8 4.8 1.81 0.52 24.0 4.8 1.45 0.78 8.8 24.0 1.25 0.69 1.34 
Rapid heartbeat 42.3 34.2 1.19 0.26 64.0 34.2 1.37 0.55 42.3 64.0 0.86 0.54 0.60 
Insomnia 49.3 36.3 1.68* 0.25 60.0 36.3 1.29 0.55 49.3 60.0 1.30 0.53 4.35 
Loss of appetite 63.1 67.8 1.02 0.26 88.0 67.8 1.91 0.72 63.1 88.0 0.53 0.70 0.90 
Weight loss 21.5 37.0 0.38*** 0.28 56.0 37.0 0.93 0.53 21.5 56.0 0.41 0.51 14.03 
Tremor/tics 9.5 6.8 1.32 0.45 24.0 6.8 1.64 0.72 9.5 24.0 0.81 0.66 0.62 
Dry mouth 38.0 33.6 1.15 0.26 68.0 33.6 2.03 0.53 38.0 68.0 0.57 0.52 1.80 
Restlessness 52.9 31.5 2.92*** 0.26 64.0 31.5 3.00* 0.55 52.9 64.0 0.97 0.53 19.31 
Note.    NMM    Nonmedical misusers (n    274); MM    Medical misusers (n    25); AU    Appropriate users (n    146). OR     Odds ratio, calculated 
with group in BOLD in the subheader (e.g., for NMM vs. AU, NMM) as the criterion and the other as the reference. SE Standard error of the effect. 
Sex and university/site were entered as covariates at the first step of this logistic regression analysis. Get “high” was not included in logistic regression 
analyses due to nil endorsement by appropriate users, a violation of logistic regression assumptions. Alpha for each omnibus x2 test was set at .003 to 
compensate for family-wise error (15 predictors used in regressions; .05/15      .003; x2  values in italics are p < .003). 
* p < .05. ** p < .01.  *** p < .001 (for pairwise OR). 
physical harm (e.g., motor vehicle accident, sexually transmitted 
disease, unplanned pregnancy). 
Regarding inattention, nonmedical misusers reported signifi- 
cantly lower levels than appropriate users but higher levels than 
nonusers. For hyperactivity, nonmedical misusers reported signif- 
icantly lower levels than medical misusers, but higher levels than 
nonusers. Thus, nonmedical misusers may be using stimulants to 
address subthreshold ADHD, and self-medication may be a viable 
explanation for the behavior of some nonmedical misusers (Rabi-  
ner et al., 2009). Misusers endorsed levels of sensation seeking that 
were significantly higher than nonusers and appropriate users. This 
is consistent with research linking sensation seeking to substance 
abuse (Carlson, Johnson & Jacobs, 2010; Dunlop & Romer, 2010; 
Zuckerman, 1994). Group differences on perfectionism subscales 
were also evident. Most notable, perhaps, was that nonmedical 
misusers endorsed higher perceived parental pressure relative to 
nonusers. Thus, perception of parental expectations for academic 
success may moderate the misuse of stimulants among those 
without a prescription. When asked about sources for obtaining 
stimulants, 81% of nonmedical misusers reported getting them 
from friends, closely resembling previous findings (77.8%; Bar- 
rett, Darredeau, Bordey, & Pihl, 2005). This suggests that some— 
and potentially many— college students with prescription stimu- 
lants are taking their medication in smaller doses or less often than 
prescribed as there seem to be “leftovers” available to sell or share. 
Limitations 
First, the medical misuser group was small (n 25), and this 
limited power to detect differences between this and other groups. 
Given that this group reported very high rates of problematic 
consequences that were often not statistically significantly differ- 
ent from other groups, more research with individuals who misuse 
stimulant prescriptions is warranted. Next, our assessments of 
substance use and ADHD symptoms were limited to self-report 
measures, and future research might use corroborating sources 
(e.g., biochemical and parent-report measures, respectively). An- 
other limitation was related to reports of type and dose of stimu- 
lants. We attempted to gather this information but participant 
responses reflected confusion or lack of knowledge. Further, data 
regarding frequency of misuse, duration of use, and amount typi- 
cally consumed are lacking. Future research should address such 
details to extend our appreciation for differences among user 
groups. Another limitation was related to the overselection of 
stimulant users, which increased power but decreased representa- 
tiveness. Further, although the current data were derived from four 
universities, the findings may not fully generalize to groups un- 
derrepresented in this sample (see McCabe, Teter, & Boyd, 2004). 
Finally, while geographic region and Greek affiliation have been 
shown to potentially add to risk for illicit stimulant use in college 
(McCabe et al., 2005), we did not consider the impact of these 
variables in the current study; researchers should include these in 
the design of future studies. 
Conclusions 
These findings reinforce that the misuse of stimulants is asso- 
ciated with other risks, such as that for polysubstance misuse. 
However, stimulant misuse by itself, even for academic reasons, 
may have concerning side effects (Graham et al., 2011). One 
university’s decision to change its honor code to include stimulant 
misuse as an “improper assistance” violation indirectly supports 
the call to proactively address this issue (Arria & DuPont, 2010;  
Diller, 2010; Wilens et al., 2008). Additionally, roughly 14% of 
students in this sample misused a prescription. Further, 81% of 
nonmedical misusers obtained stimulants from a friend. These two 
findings emphasize the importance of prescribers closely monitor- 
ing consumption and openly discussing consequences of misuse 
and diversion with college students. For example, if a student 
reports only taking medication on weekdays, then 30 pills might 
last 6 weeks rather than 4. Therefore, prescribers may want to 
evaluate how often students are taking their medication and pre- 
scribe accordingly to reduce the quantity of stimulants available to 
be diverted. 
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